You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 2, 2024

CLINICAL TRIALS PROFILE FOR BESREMI

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for BESREMI

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05467553 ↗	A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection	Not yet recruiting	PharmaEssentia	Phase 2	2022-08-31	This is an open-label, randomized, multi-center study in patients with chronic HBV and HDV co-infection.
NCT05467553 ↗	A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection	Not yet recruiting	National Taiwan University Hospital	Phase 2	2022-08-31	This is an open-label, randomized, multi-center study in patients with chronic HBV and HDV co-infection.
NCT05485948 ↗	A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU	Active, not recruiting	PharmaEssentia	Phase 2	2021-10-08	This study is a phase II single-arm study designed to evaluate the efficacy and safety of P1101 in Chinese PV patients who are intolerance or resistance to HU.
NCT05494528 ↗	Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy	Recruiting	PharmaEssentia	N/A	2021-05-04	This is an open-label, multicenter, randomized, active control study, comparing P1101 monotherapy to entecavir monotherapy in patients with HBeAg-negative chronic hepatitis B under long-term nucleos(t)ide analogue therapy.
NCT05494528 ↗	Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy	Recruiting	National Taiwan University Hospital	N/A	2021-05-04	This is an open-label, multicenter, randomized, active control study, comparing P1101 monotherapy to entecavir monotherapy in patients with HBeAg-negative chronic hepatitis B under long-term nucleos(t)ide analogue therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for BESREMI

Condition Name

Chart
Table

Condition Name for BESREMI
Intervention	Trials
Chronic Hepatitis B Virus Infection	1
Hepatitis D	1
Polycythemia Vera	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for BESREMI
Intervention	Trials
Hepatitis A	2
Hepatitis	2
Hepatitis D	1
Herpesviridae Infections	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for BESREMI

Trials by Country

Map
Table

Trials by Country for BESREMI
Location	Trials
Taiwan	2
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for BESREMI

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for BESREMI
Clinical Trial Phase	Trials
Phase 2	2
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for BESREMI
Clinical Trial Phase	Trials
Not yet recruiting	1
Recruiting	1
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BESREMI

Sponsor Name

Chart
Table

Sponsor Name for BESREMI
Sponsor	Trials
PharmaEssentia	3
National Taiwan University Hospital	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for BESREMI
Sponsor	Trials
Industry	3
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.